Search results for "OUTCOME"

showing 10 items of 5148 documents

Repeated resection for recurrent intrahepatic cholangiocarcinoma: A retrospective German multicentre study.

2020

Background Tumour recurrence is common after resection of intrahepatic cholangiocarcinoma (ICC). Repeated resection is a potential curative treatment, but outcomes are not well-defined thus far. The aim of this retrospective multicentre cohort study was to show the feasibility and survival of repeated resection of ICC recurrence. Methods Data were collected from 18 German hepato-pancreatico-biliary centres for patients who underwent repeated exploration of recurrent ICC between January 2008 and December 2017. Primary end points were overall (OS) and recurrence-free survival from the day of primary and repeated resection. Results Of 156 patients who underwent repeated exploration for recurre…

medicine.medical_specialtyResectionCholangiocarcinomaCohort Studies03 medical and health sciences0302 clinical medicineMedicineHepatectomyHumansIntrahepatic CholangiocarcinomaRetrospective StudiesHepatologybusiness.industryPrimary resectionRecurrent Intrahepatic Cholangiocarcinoma3. Good healthTumor recurrenceSurgeryTreatment OutcomeBile Duct NeoplasmsMedian timeCurative treatment030220 oncology & carcinogenesis030211 gastroenterology & hepatologyNeoplasm Recurrence LocalbusinessCohort studyLiver international : official journal of the International Association for the Study of the LiverReferences
researchProduct

Does prehospital care by physicians result in a better outcome than resuscitation by other EMS personnel?

1993

medicine.medical_specialtyResuscitationEmergency Medical Servicesbusiness.industryPublic healthResuscitationTreatment outcomeEmergency Nursingmedicine.diseaseOutcome (game theory)United StatesHeart ArrestEuropeEmergency Medical TechniciansTreatment OutcomePhysiciansEmergency MedicineEmergency medical servicesMedicineHumansWounds and InjuriesMedical emergencyCardiology and Cardiovascular MedicinebusinessIntensive care medicineResuscitation
researchProduct

Tangential Venous Resections during Robotic-Assisted Pancreaticoduodenectomy: the Results of a Case Series (with Video)

2020

Introduction: Despite the potential advantages in terms of microdissection and microsuturing capabilites, the robotic approach for borderline resectable pancreatic cancer is scarcely reported. Methods: We report our technique for a robotic-assisted pancreaticoduodenectomy with tangential Portal/ Superior Mesenteric Vein resection/reconstruction (RPD PV/SMV).We also compared the surgical outcomes of eight consecutive patients undergoing RPD PV/SMV with that of sixty patients who underwent robotic-assisted pancreaticoduodenectomy (RPD) in the same period of time. Results: A total of eight consecutive patients underwent RPD PV/SMV. We observed an increased estimated blood loss (550 vs 280 mL, …

medicine.medical_specialtyRobotic assistedmedicine.medical_treatmentPancreaticoduodenectomyResection03 medical and health sciencesMesenteric VeinsPancreatectomy0302 clinical medicineRobotic Surgical ProceduresBlood lossBorderline resectablemedicineHumansSuperior mesenteric veinRetrospective StudiesPortal Veinbusiness.industryGastroenterologyPancreaticoduodenectomyVascular resectionSurgeryPancreatic NeoplasmsVideo techniqueTreatment Outcome030220 oncology & carcinogenesisOperative time030211 gastroenterology & hepatologySurgeryRobotic-assisted pancreaticoduodenectomybusinessHospital stay
researchProduct

Diabetes mellitus, periapical inflammation and endodontic treatment outcome

2012

The possible connection between chronic oral inflammatory processes, such as apical periodontitis and periodontal disease (PD), and systemic health is one of the most interesting aspects faced by the medical and dental scientific community. Chronic apical periodontitis shares important characteristics with PD: 1) both are chronic infections of the oral cavity, 2) the Gram-negative anaerobic microbiota found in both diseases is comparable, and 3) in both infectious processes increased local levels of inflammatory mediators may have an impact on systemic levels. One of the systemic disorders linked to PD is diabetes mellitus (DM); is therefore plausible to assume that chronic apical periodont…

medicine.medical_specialtyRoot canalTreatment outcomeDentistryMalalties periodontalsPeriapical inflammationAsymptomaticEndodonticsDiabetes ComplicationsInternal medicineDiabetes mellitusMedicineAnimalsHumansPeriodontitisGeneral DentistryPeriodontitisInflammationPeriapical periodontitisDiabetisbusiness.industryDiabetesReview-ArticleEndodonticsmedicine.disease:CIENCIAS MÉDICAS [UNESCO]InflamacióRoot Canal Therapymedicine.anatomical_structureTreatment OutcomeOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASSurgerymedicine.symptomPeriodontal diseasebusinessPeriapical Periodontitis
researchProduct

Laparoscopic sacrocolpopexy in the treatment of vaginal vault prolapse: 8 years experience

2009

Abstract Objective The aim of this study was to evaluate the long-term results of a laparoscopic sacrocolpopexy for the treatment of vaginal vault prolapse. Study design Between January 1999 and January 2007, 165 laparoscopic sacrocolpopexy procedures, using a polypropylene mesh, were performed on women affected by vaginal vault prolapse. Intraoperative complications included: 5 bladder injuries and 3 sigmoid perforations. Postoperative complications included: 10 cases of fever, 5 cases of lumbosciatica, 15 cases of detrusor overactivity, 2 cases of vaginal haematoma, and 5 cases of minimal dispareunia. At 1, 6 and 12 months after surgery, a clinical evaluation was carried out for all patie…

medicine.medical_specialtySacrocolpopexy Laparoscopic treatment Pelvic prolapse Vaginal vault prolapseVaginal vault prolapsemedicine.medical_treatmentHysterectomyPolypropylenesPelvic Organ ProlapseGynecologic Surgical ProceduresHysterectomy VaginalmedicineHumansLaparoscopyAgedRetrospective Studieslaparoscopic sacrocolpopexySacrocolpopexyHysterectomymedicine.diagnostic_testLaparoscopic treatmentSacrococcygeal Regionbusiness.industryObstetrics and GynecologyMiddle AgedSurgical MeshPelvic cavitySettore MED/40 - Ginecologia E Ostetriciapolypropylene meshSurgeryEndoscopyTreatment OutcomeSurgical meshmedicine.anatomical_structureReproductive MedicineVaginaFemaleLaparoscopyVaginal vaultbusinessVaginal Vault ProlapsePelvic prolapseFollow-Up Studies
researchProduct

Efficacy and acceptance of the sacral neuromodulation in the treatment of female lower urinary tract dysfunctions.

2017

medicine.medical_specialtySacrum030232 urology & nephrologyUrologyMEDLINEElectric Stimulation Therapylower urinary tract dysfunctionsacral neuromodulationFemale lower urinary tract03 medical and health sciences0302 clinical medicineMedicineHumansElectric stimulation therapyProspective StudiesProspective cohort study030219 obstetrics & reproductive medicineUrinary bladderbusiness.industryUrinary retentionUrinary Bladder OveractiveObstetrics and GynecologyMiddle AgedPatient Acceptance of Health CareUrinary RetentionSacrummedicine.anatomical_structureTreatment OutcomeSacral nerve stimulationFemalemedicine.symptombusinessMinerva ginecologica
researchProduct

[S1 Herpes zoster localization: acute urinary retention in woman].

2011

Acute urinary retention in women is rare. The varicella-zoster virus causes inflammatory lesions of the sensory-root ganglions, meninges and, less frequently, spinal cord. Herpes zoster has been reported to affect, although rarely, lower urinary tract innervations, and acute urinary retention can be thought to occur in the presence of sacral dermatome involvement. Usually it is located in S2–4 dermatome and the prognosis for acute urinary retention is benign resolving in about 20 days. We present a case in which the S1 dermatome was interested and acute urinary retention developed. After 10 days of specific therapy and self catheterism the problem resolved.

medicine.medical_specialtySacrumUrinary systemAcyclovirGastroenterologyAntiviral AgentsHerpes ZosterVirusS1 dermatomeInternal medicinemedicineHumansIntermittent Urethral CatheterizationUrinary retentionbusiness.industryMeningesGeneral MedicineMiddle AgedUrinary RetentionSpinal cordSacrumSurgerymedicine.anatomical_structureTreatment OutcomeDermatomeAcute DiseaseFemalemedicine.symptombusinessSpinal Nerve RootsUrologia
researchProduct

Prevention of Atherosclerosis by Interference with the Vascular Nitric Oxide System

2009

Nitric oxide (NO) produced by endothelial NO synthase (eNOS) represents an anti-atherosclerotic principle. NO bioavailability is decreased in atherosclerosis due to increased NO inactivation by reactive oxygen species and reduced NO synthesis. Various types of vascular pathophysiology are associated with oxidative stress, with NADPH oxidases as the major source of reactive oxygen species. These inactivate NO. Also, oxidative stress is likely to be the main cause for oxidation of the essential NOS cofactor, tetrahydrobiopterin (BH(4)). A lack of BH(4) leads to eNOS uncoupling (i.e., uncoupling of oxygen reduction from NO synthesis in eNOS). Based on these pathomechanisms, the therapeutic pot…

medicine.medical_specialtySepiapterinNitric Oxide Synthase Type IIImedicine.drug_classGTP cyclohydrolase INitric Oxidemedicine.disease_causeRenin inhibitorNitric oxidechemistry.chemical_compoundEnosInternal medicineDrug DiscoverymedicineAnimalsHumansHypolipidemic AgentsPharmacologybiologyArteriesTetrahydrobiopterinAtherosclerosisbiology.organism_classificationNitric oxide synthaseOxidative StressTreatment OutcomeEndocrinologychemistrybiology.proteinOxidative stressSignal Transductionmedicine.drugCurrent Pharmaceutical Design
researchProduct

Current insights into the German lipoprotein apheresis standard: PCSK9-inhibitors, lipoprotein apheresis or both?

2017

Abstract According to current European guidelines, lipid lowering therapy for progressive cardiovascular disease including cardiovascular events has to be focused on a target level for LDL-C. In contrast for Lp(a) a threshold has to be defined with respect to the method of measurement. However, due to new lipid lowering drug developments like PCSK9-inhibitors (PCSK-9-I) a therapeutic algorithm for patients with severe hypercholesterolemia or isolated Lipoprotein(a)-hyperlipoproteinemia with progressive cardiovascular disease may be necessary to manage the use of PCSK9-I, lipoprotein apheresis (LA) or both. The therapeutic approach for patients with homozygous familial hypercholesterolemia i…

medicine.medical_specialtySerine Proteinase InhibitorsDiseaseFamilial hypercholesterolemia030204 cardiovascular system & hematologyRisk AssessmentHyperlipoproteinemia Type II03 medical and health sciencesTherapeutic approach0302 clinical medicineRisk FactorsInternal medicineGermanyInternal MedicinemedicineHumans030212 general & internal medicinePCSK9 Inhibitorsbiologybusiness.industryPCSK9Anticholesteremic AgentsPCSK9 InhibitorsGeneral MedicineLipoprotein(a)Cholesterol LDLmedicine.diseaseCombined Modality TherapyEndocrinologyTreatment OutcomeCardiovascular Diseasesbiology.proteinCardiologyBlood Component Removallipids (amino acids peptides and proteins)Proprotein Convertase 9Cardiology and Cardiovascular MedicinebusinessLipoprotein apheresisBiomarkersLipoproteinLipoprotein(a)Atherosclerosis. Supplements
researchProduct

Treatment strategies for cancer patients with breakthrough pain.

2009

Breakthrough pain (BTP) is a transitory flare of pain superimposed on an otherwise stable pain pattern in patients treated with opioids. It is normally severe in intensity, has a rapid onset, has a variable duration (on average 30 min) and is considered a negative prognostic factor. OBJECTIVE: To verify the data in the literature about therapy strategies for BTP in cancer patients. METHODS: To find clinical trials investigating drug therapy for BTP. CONCLUSION: The treatment of BTP in cancer patients receiving opioids is principally based on the use of opioids, preferentially with a short onset. Fentanyl delivered by recently developed systems seems to be the best option to cover the tempor…

medicine.medical_specialtySettore MED/06 - Oncologia MedicaBreakthrough PainPainFentanylPharmacotherapyNeoplasmsInternal medicinemedicineAnimalsHumansPharmacology (medical)In patientPain MeasurementPharmacologybusiness.industryCancerGeneral Medicinemedicine.diseaseAnalgesics OpioidFentanylClinical trialTreatment OutcomeAnesthesiaTreatment strategycancer pain opiods breakthrough painbusinessCancer painmedicine.drug
researchProduct